Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
v, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc., a buy now, pay later (BNPL) company, lost nearly a quarter of its market capitalization on December 18th following a damning report released by...
-
SAN FRANCISCO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- On December 11, 2024, a second investor in The Toronto-Dominion Bank (NYSE: TD) filed a class action lawsuit that expanded the Class Period in the...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- On October 16, 2024, Silvaco Group, Inc. (NASDAQ: SVCO) shares crashed to their lowest level since the company conducted its May 2024 IPO at $19 per...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- AstraZeneca PLC (NASDAQ: AZN) is facing a significant crisis in China as authorities there investigate the company for alleged fraud, illegal drug...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- On December 4, 2024, automation technology company Symbotic Inc. (NASDAQ: SYM) filed restated financial statements for the quarters ended December...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Humacyte, a biotechnology company focused on regenerative medicine, is now facing an investor class action alleging that the company misled investors...
-
SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- PACS Group, Inc. (NYSE: PACS) and certain of its C-Suite officers are now entangled in a securities class action lawsuit, following allegations of...